SBIR/STTR Research Award

Rapid diagnostic tools for wound infections

Award identifier 03ae8dad10b4622c648cc2c65a1d11ea939ba1294cedf9107e4a0dc1e692f779Awarding agency Department of Defense · Army

Award amount

$1,899,828

Program and phase

SBIR · Phase II

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
SPECTRAL PLATFORMS INC
Proposal award date
2013-03-19
Contract end date
2018-01-28
UEI
EP2ZJCLTVMZ9
Solicitation number
2011.1
Topic code
A11-021

Research abstract

Wound infections that result in bacteremia and even mortality are a significant problem among soldiers with soft tissue/burn injuries.Overall morbidity associated with such wounds could be reduced substantially if the infectious etiology of these infections was clarified rapidly, especially for the presence of select multidrug-resistant pathogens. Current methods for diagnosing wound infections are too time-consuming to be relevant, and so new diagnostic tools are required.In our Phase I, we developed and demonstrated a new optical biomarker that can detect bacteria at clinically relevant concentrations.We demonstrated the efficacy of this biomarker by accurately characterizing the presence/absence of bacteria in the plasma of blood obtained from hospitalized febrile patients.We also demonstrated a UV Raman modulation scheme that could be used to distinguish different pathogens.In the Phase II proposed here, we will extend this biomarker to characterize wound infections.We will show that we can accurately detect, characterize and distinguish the presence of MDR pathogens in the milieu of commensal bacteria that are often present at a wound site.With the availability of drugs that can target even the most drug-resistant pathogens, rapid confirmation of the presence of such pathogens can improve the outcome for wounded soldiers.In our Phase I, we developed and demonstrated a new optical biomarker that can detect bacteria at clinically relevant concentrations.We demonstrated the efficacy of this biomarker by accurately characterizing the presence/absence of bacteria in the plasma of blood obtained from hospitalized febrile patients.We also demonstrated a UV Raman modulation scheme that could be used to subclassify pathogens.In the Phase II proposed here, we will extend this biomarker to characterize wound infections.We will show that we can accurately detect, characterize and distinguish the presence of MDR pathogens in the milieu of commensal bacteria that are often present at a wound site.With the availability of drugs that can target even the most drug-resistant pathogens, rapid confirmation of the presence of such pathogens can improve the outcome for wounded soldiers.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2011–2013). Reported award amounts total $2,198,713. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.